Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Akeso Appoints Prof. Bradley Monk as Lead Gynecologic Oncology Advisor and Chair of the Steering Committee 2020-06-24 12:55
InxMed Released Research Data of "FAK inhibitor IN10018 overcomes drug resistance of KRAS G12C inhibition" at 2020 AACR Annual Meeting 2020-06-24 08:41
IgNova Files Patent Application on Antibody Against COVID-19 2020-06-24 02:13
ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA 2020-06-22 23:00
Cutting-edge Multidisciplinary Approaches to Minimally Invasive Cancer Treatment Utilizing JCI MN COLLOIDAL IODINE (R) and Possible Effect on SARS-CoV-2 2020-06-22 13:00
Qiming's Portfolio Company SinocellTech Lands on STAR Market 2020-06-22 12:20
Innovent Announces The Stock Exchange of Hong Kong Limited Approved the "B" Marker Removal from the Company's Stock Symbol in the HKEX 2020-06-22 07:40
Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors 2020-06-22 07:15
Ascentage Pharma Submits Its First New Drug Application to National Medical Products Administration, for HQP1351, the First Third-Generation BCR-ABL Inhibitor in China 2020-06-18 17:30
Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China 2020-06-18 12:00
ASC40 (TVB-2640) Significantly Reduced Liver Fat With a 61% Responder Rate in Phase 2 NASH Trial 2020-06-17 20:30
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B 2020-06-17 13:20
ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR) 2020-06-16 14:09
New Capture the Fracture® Partnership Aims for 25% Reduction in the Incidence of Hip and Vertebral Fractures Due to Osteoporosis by 2025 2020-06-16 08:00
Investigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Insulin Glargine U100 in Phase 2 Trial 2020-06-15 07:30
Switching to Ozempic(R) from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice 2020-06-15 06:15
Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board 2020-06-11 18:00
Menarini Group Completes a Solid Year of Operating Performance 2020-06-10 23:42
Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 2020-06-10 08:45
L.E.A.F. Pharmaceuticals Lead Investigational Product for Lung and Colorectal Cancers, LEAF-1401, Featured at the 2020 Virtual Annual Meeting of the American Society of Clinical Oncology (ASCO) 2020-06-10 03:15
1 170 171 172 173 174 247